Artery Stiffening: A Key to Age-Related Heart & Lung Decline?

Shortness of breath is a common complaint among older adults, often presenting a diagnostic puzzle for clinicians. While heart and lung conditions are frequently investigated, a significant number of cases remain unexplained. New research from Yale School of Medicine suggests that progressive stiffening of the pulmonary artery – the major blood vessel connecting the heart to the lungs – could be a key factor contributing to this age-related breathlessness. The study, published in Aging Cell, offers a potential explanation for why so many older individuals experience this frustrating symptom despite appearing healthy on standard tests.

The Puzzle of Unexplained Breathlessness

Approximately one in three people over 65 report experiencing shortness of breath to their doctors, according to Dr. Edward Manning, assistant professor of medicine in the Section of Pulmonary, Critical Care, and Sleep Medicine (Yale-PCCSM) at Yale School of Medicine. Often, extensive medical evaluations – including assessments of heart, lung, and artery function – fail to identify a clear cause. This leaves both patients and physicians searching for answers. The focus of biomedical research is increasingly turning towards understanding how the body changes with age and why physical function declines, and this new study adds a crucial piece to that puzzle.

Pulmonary Artery Stiffening: A Potential Culprit

The Yale study focused on the pulmonary artery, hypothesizing that changes within this vessel could contribute to breathlessness even when other indicators appear normal. Researchers used preclinical models to examine the mechanical, structural, and molecular changes occurring in the pulmonary artery as it ages. Their work points to progressive stiffening of the artery as a potential biomarker and therapeutic target for age-related declines in both heart and lung function. This stiffening may impede blood flow and increase the effort required to breathe, even in the absence of overt disease.

Beyond Longevity: The Importance of Functional Years

Dr. Manning emphasizes that the goal isn’t simply to extend lifespan, but to ensure those added years are lived with continued functionality. “It’s more than just trying to live longer,” he says. “From a geroscience perspective, we want the added years of life to remain functional.” Understanding the mechanisms behind age-related breathlessness is a critical step towards achieving this goal.

Cellular Changes in Aging Lungs

Further research, published in March 2026, expands on these findings, revealing that not all lung cells age at the same rate. A study led by Naftali Kaminski, MD, Boehringer Ingelheim Pharmaceuticals, Inc. Professor of Medicine (Pulmonary) at Yale School of Medicine, and first author Ruben De Man, analyzed data from 60 human lungs, ranging in age from 11 to 80 years old. Using single-cell RNA sequencing, the researchers identified specific cell types particularly vulnerable to aging. This comprehensive analysis suggests that targeting these defective cells could lead to new treatments for age-related lung diseases. The study, published in Nature Communications, highlights the potential to modify the aging process in the lungs, rather than simply accepting it as inevitable.

Alveolar and Endothelial Cells: Key Areas of Change

The single-cell analysis revealed that alveolar epithelial and endothelial cells – cells lining the air sacs and blood vessels in the lungs – exhibit the most significant transcriptional changes with age. Specifically, the study found a decrease in surfactant-expressing cells within the alveoli, which are crucial for maintaining lung elasticity. Capillary cells also showed signs of losing differentiation and function. Interestingly, the researchers also observed an increase in somatic mutations within these cell types as age increased. Details of the study, including conflict of interest statements, are available through PubMed.

What Does This Mean for Patients?

These findings don’t immediately translate into new treatments, but they offer a more nuanced understanding of why older adults experience breathlessness. The identification of specific cellular changes and potential biomarkers opens avenues for developing targeted therapies. For example, interventions aimed at preserving the function of alveolar epithelial and endothelial cells could potentially improve lung function and reduce breathlessness. It’s important to note that this research is still in its early stages, and further investigation is needed to confirm these findings and translate them into clinical practice.

Understanding Single-Cell RNA Sequencing

Single-cell RNA sequencing is a powerful technique that allows researchers to analyze the gene expression of individual cells. This provides a much more detailed picture of cellular changes than traditional methods, which analyze the average gene expression across a population of cells. By identifying the specific genes that are altered in aging lung cells, researchers can gain insights into the underlying mechanisms of age-related lung disease.

The Role of Inflammation and Senescence

While the study identified increased transcriptional entropy with age, it surprisingly did not find a significant increase in cells expressing common senescence signatures. Senescence is a process where cells stop dividing but remain metabolically active, often contributing to inflammation. The lack of increased senescence suggests that other mechanisms, such as the stiffening of the pulmonary artery and the decline in alveolar cell function, may be more important drivers of age-related breathlessness.

What Comes Next: Research and Potential Therapies

The Yale research team is continuing to investigate the mechanisms underlying pulmonary artery stiffening and alveolar cell dysfunction. Future studies will focus on identifying potential therapeutic targets and developing interventions to prevent or reverse these age-related changes. This includes exploring the possibility of targeted cell therapies to restore lung function. Further research is also needed to determine whether these findings apply to diverse populations and to understand the interplay between genetic factors and environmental exposures. The ongoing work represents a significant step towards improving the quality of life for older adults and addressing the often-unexplained symptom of shortness of breath. More information about the initial study can be found on the Yale Medicine website.